Skip to content

Author

Abhishek Chatterjee

We have 4 of 25 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Development of m6A Readers for Enhanced Recognition In Vitro via Genetic Code Expansion

The YTH domain was recently demonstrated as a promising tool for recognizing and regulating m6A-modified RNAs. However, the deficiency in binding affinity (micromolar range) and selectivity (off-target binding) for m6A of the wild-type YTH domain limit its sensitivity and accuracy for m6A recognition. Engineering strat...

Michael S. Addo, Elise D. Ficaretta, Yi-Bo Chang et al. · 0 citations
Review Open access Sep 2026

Site-Specific Protein Bioconjugation Through Cellular Incorporation of Noncanonical Amino Acids

Traditional methods for protein bioconjugation, such as those targeting canonical amino acid residues, often suffer from a lack of site-specificity, yielding heterogeneous conjugates. Genetic code expansion (GCE) technology offers an exciting alternative, enabling site-specific incorporation of noncanonical amino acids...

R. Sarkar, Manas Joshi, Abhishek Chatterjee · 0 citations
Open access Sep 2026

Repurposing engineered aminoacyl-tRNA synthetases for proximity-dependent protein labeling through the release of aminoacyl-AMP intermediate

Over the past two decades, engineering efforts have yielded aminoacyl-tRNA synthetases (aaRSs) capable of charging diverse noncanonical amino acids (ncAAs). Here, we report an unexpected and exploitable activity of these engineered aaRSs: In the absence of their cognate tRNA, aaRSs can release the ncAA-AMP intermediate...

T. Yared, Elise D. Ficaretta, Lena A. Voss et al. · 0 citations
2026

Site-Specific Chemical Conjugation of Recombinant Proteins onto the AAV Capsid.

This platform provides a powerful approach for engineering next-generation AAV vectors with customizable targeting profiles for diverse therapeutic applications and preserves AAV integrity and infectivity, and enables programmable retargeting of AAV tropism toward disease-relevant receptors.

Quan Pham, Jake Glicksman, Abhishek Chatterjee · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.